AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| XTE | Ann: XTEK Appoints a New Non Executive Director | 24/04/18 | 0 | 37 | |||
|
|||||||
| XTE | Price Crash | 24/04/18 | 12 | 1.5K | |||
|
|||||||
| XTE | Ann: XTEK awarded A$1.4m Purchase Order from the ADF | 18/04/18 | 9 | 1.4K | |||
|
|||||||
| XTE | Ann: Change of Director's Interest Notice for Uwe Boettcher | 03/04/18 | 2 | 456 | |||
|
|||||||
| XTE | Ann: Change of Director's Interest Notice for Uwe Boettcher | 03/04/18 | 2 | 426 | |||
|
|||||||
| XTE | Ann: XTEK MARKET UPDATE | 22/03/18 | 59 | 12K | |||
|
|||||||
| XTE | Ann: XTEK Half Yearly Report - Appendix 4D | 27/02/18 | 4 | 912 | |||
|
|||||||
| XTE | Ann: XTEK Investor Presentation Feb 18 | 27/02/18 | 9 | 1.6K | |||
|
|||||||
See All Discussions
ASX News